Cited by 257Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and TreatmentNeuroendocrine Tumor Research Advances

The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer

Poley, J W, Kluijt, I, Gouma, D J, Harinck, F, Wagner, A, Aalfs, C, van Eijck, C H J, Cats, A +4 more·2009·The American Journal of Gastroenterology

Abstract

OBJECTIVES: Approximately 10-15% of all pancreatic cancers (PCs) may be hereditary in origin. We investigated the use of endoscopic ultrasonography (EUS) for the screening of individuals at high risk for developing PC. In this paper the results of first-time screening with EUS are presented. METHODS: Those eligible for screening in this study were first-degree family members of affected individuals from familial pancreatic cancer (FPC) families, mutation carriers of PC-prone hereditary syndromes, individuals with Peutz-Jeghers syndrome, and mutation carriers of other PC-prone hereditary syndromes with clustering (> or =2 cases per family) of PC. All individuals were asymptomatic and had not undergone EUS before. RESULTS: Forty-four individuals (M/F 18/26), aged 32-75 years underwent screening with EUS. Thirteen were from families with familial atypical multiple-mole melanoma (FAMMM), 21 with FPC, 3 individuals were diagnosed with hereditary pancreatitis, 2 were Peutz-Jeghers patients, 3 were BRCA1 and 2 were BRCA2 mutation carriers with familial clustering of PC, and 1 individual had a p53 mutation. Three (6.8%) patients had an asymptomatic mass lesion (12, 27, and 50 mm) in the body (n=2) or tail of the pancreas. All lesions were completely resected. Pathology showed moderately differentiated adenocarcinomas with N1 disease in the two patients with the largest lesions. EUS showed branch-type intraductal papillary mucinous neoplasia (IPMN) in seven individuals. CONCLUSIONS: Screening of individuals at a high risk for PC with EUS is feasible and safe. The incidence of clinically relevant findings at first screening is high with asymptomatic cancer in 7% and premalignant IPMN-like lesions in 16% in our series. Whether screening improves survival remains to be determined, as does the optimal screening interval with EUS.

Integrity signals

Registry

Crossref · 10.1038/ajg.2009.276

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Medical imaging has been shown to detect precancerous tissue changes in the pancreas among individuals at high risk.

    “The ability to detect precancerous tissue changes in the pancreas using medical imaging among individuals at high risk has also been shown.110,122–125”

    From Early detection of pancreatic cancer (2020) · cites this paper as [124]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Poley, J. W., Kluijt, I., Gouma, D. J., Harinck, F., Wagner, A., Aalfs, C., van Eijck, C. H. J., Cats, A., Kuipers, E. J., Nio, Y., Fockens, P., & Bruno, M. J.
Affiliations
  • Erasmus MC (NL)
  • The Netherlands Cancer Institute (NL)
  • Amsterdam UMC Location University of Amsterdam (NL)
Corresponding author
Poley, J W
Venue
The American Journal of Gastroenterology
Published
2009-06-02
Volume
104
Issue
9
Pages
2175-2181
ISSN
  • 0002-9270 (ISSN-L)
  • 1572-0241
OpenAlex
W2028828517
Cited by
257
References
38
Citations by year
2026: 3 · 2024: 7 · 2023: 12 · 2022: 9 · 2021: 4 · 2020: 8 · 2019: 11 · 2018: 23 · 2017: 18 · 2016: 18 · 2015: 23 · 2014: 25 · 2013: 15 · 2012: 25
FWCI
13.48
Type
journal article
Language
en
Open access
closed
Locations
  • The American Journal of Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
  • Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
Keywords
pancreatic cancer screening, endoscopic ultrasound, hereditary pancreatic cancer, familial pancreatic cancer, Peutz-Jeghers syndrome, hereditary pancreatitis, BRCA1, BRCA2, TP53 mutation, intraductal papillary mucinous neoplasm, pancreatic ductal adenocarcinoma, premalignant pancreatic lesions, high-risk individuals
MeSH terms
Adult, Aged, Female, Humans, Male, Mass Screening, Middle Aged, Pancreatic Neoplasms, Endosonography, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review